Delivery Order SPE2DB22D3301-SPE2DB25FX5GV

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order worth $2,320.37 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Sucralfate 1 GM Tablets in quantities of 90s. It is an open-competition contract with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range...
This federal contract award, valued at $4,382.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary mechanism for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV9UL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, with a ceiling value of $39,810.57 and a completion date of April 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,361.04 firm-fixed-price delivery order is for the supply of 4,563,652,923 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a completion date of February 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,514,018 sucralfate 1 gram tablets. The contract has a ceiling value of $8,282.75 and a period of performance ending on May 7, 2024. The contract is a firm-fixed-price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sucralfate 1 gm/10 ml suspension. The $4,597.18 firm fixed price contract has a completion date of June 23, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.00 fixed-price delivery order contract is for the supply of sucralfate 1 gram/10 milliliter suspension in 420 milliliter bottles. The contract has an ultimate completion date of December 3, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,666.35, is for the delivery of Sucralfate 1 GM Tablets (90 count) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has established itself as a key vendor for federal healthcare...
This federal contract award is for a delivery order with a ceiling value of $1,326.02, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of Sucralfate 1 GM Tablet 90S, a pharmaceutical product, with a period of performance through November 19, 2024. The contract is a firm-fixed price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5GV
    Delivery Order

This federal contract award, valued at $3,918.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM Tablets in 90-count packages. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 13, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The current award is a task order issued under this larger IDC contract.

The contract was not set aside for any specific business category. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant presence in providing medical products and supplies to various federal agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation.

Generated 5/20/25, 1:48 PM